Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. endocrine study
Show results for
Products
News
Articles

Refine by
Date

  • Older

Endocrine Study Articles & Analysis

5 news found

Regor announces the first patient dosed in the U.S. in the Phase I clinical trial for RGT-419B, a CDK2/4/6 inhibitor for advanced/metastatic breast cancer

Regor announces the first patient dosed in the U.S. in the Phase I clinical trial for RGT-419B, a CDK2/4/6 inhibitor for advanced/metastatic breast cancer

The Phase I clinical trial is in the form of non-randomized, open-label first-in-human clinical study, exploring ascending dose of RGT-419B in hormone receptor-positive HER-2 receptor-negative patients with advanced or metastatic breast cancer under monotherapy or combination endocrine therapy conditions. The study was initiated in March 2022 and ...

ByRegor Pharmaceuticals Inc.


Zucara Therapeutics Doses First Subject in Phase 1 Trial of ZT-01

Zucara Therapeutics Doses First Subject in Phase 1 Trial of ZT-01

The SAD portion of the study will enroll 40 healthy volunteers who will receive one of five escalating doses of ZT-01. ...

ByZucara Therapeutics Inc.


Zucara Therapeutics Doses First Subject in Phase 1 Trial of ZT-01

Zucara Therapeutics Doses First Subject in Phase 1 Trial of ZT-01

The SAD portion of the study will enroll 40 healthy volunteers who will receive one of five escalating doses of ZT-01. ...

ByZucara Therapeutics Inc.


New scientific study confirms health concerns about glyphosate-based herbicides

New scientific study confirms health concerns about glyphosate-based herbicides

Endocrine effects and altered reproductive and developmental parameters were observed in both male and female rats, when exposed at a dose level that has been considered safe for humans. The findings of the study, which takes into account exposure from the in utero stage and all throughout adulthood, are particularly relevant considering ...

ByHealth and Environment Alliance (HEAL)


Infants at greater risk from food packaging chemical

Infants at greater risk from food packaging chemical

Bisphenol A (BPA) is a commonly used chemical in the manufacture of food packaging and there are concerns over its safety, particularly for young children. A recent study suggests that there is a five times greater BPA plasma concentration in babies aged between three and six months compared with adults. ...

ByEuropean Commission, Environment DG

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT